HAMILTON ATLANTIC

Company

IOVANCE BIOTHERAPEUTICS, INC.

Filed

March 29, 2010

Accession Number

0001019687-10-001146

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →